Pharmstandard PJSC GDR (LSE:70SK) - Overview

Stock Report

Pharmstandard PJSC 70SK

Last Price
$-

Day Change
-|-%

As of -
- | USD
Minimum 15 Minutes Delay.

Last Close-
Day Range-
Mkt Cap-
52-Wk Range-
Yield %-
ISINUS7171401075
Volume-
P/E-
P/S-
P/CF-

Share Price

Financials
201320142015
More ...
Income Statement
Revenue55,907.6041,223.4447,194.94
Operating Income15,796.8213,692.9617,198.98
Net Income11,805.7910,841.2313,749.47
Basic EPS85.2374.5594.55
Avg. Diluted Shares Outstanding139145145
Balance Sheet
Current Assets48,985.5341,797.8356,609.37
Non Current Assets13,621.7721,022.6526,012.25
Total Assets62,607.3162,820.4782,621.62
Current Liabilities33,196.1621,300.8926,793.02
Total Liabilities34,978.8623,646.08-
Total Equity27,628.4539,174.3953,663.96
Cash Flow
Operating Cash Flow13,528.759,615.9415,625.19
Capital Expenditure-3,983.60-2,474.37-2,915.51
Free Cash Flow9,545.157,141.5712,709.68

In millions, except "Basic EPS". Currency is RUB.

Company Profile

Pharmstandard PJSC is engaged in the production and wholesale distribution of pharmaceutical and medical products. Its core business is manufacture and sales of pharmaceutical products and medical equipment and disposables.

Sector

Healthcare

Industry

Drug Manufacturers - Major

Stock Style

Small-Value

Fiscal Year Ends

December

Employees

6,450
Key Stats
More ...
Price/Earning TTM-
Price/Book-
Price/Sales TTM-
Rev Growth (3 year avg)-2.80
EPS Growth (3 year avg)-
Operating Margin % TTM36.44
Net Margin % TTM29.13
ROE TTM29.62
Debt/Equity-
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2016 Morningstar. All rights reserved.